Table 2. Patient characteristics and association with Clavien-Dino Grade 3 above complications.
| Characteristics | OR (95% CI) | P | |
|---|---|---|---|
| Univariable | |||
| Gender (Male vs. Female1) | 2.330 (1.035-5.249) | 0.041 | |
| Age (≥70 vs. <70 1) | 1.044 (0.539-2.025) | 0.898 | |
| BMI | |||
| 30-40 vs. <30 1 | 1.080 (0.540-2.159) | 0.827 | |
| ≥40 vs. <30 1 | 1.692 (0.547-5.230) | 0.360 | |
| Method of Diversion (ICUD vs. ECUD1) | 0.485 (0.216-1.092) | 0.080 | |
| Diversion type | |||
| Indiana Pouch vs. Ileal conduit1 | 2.010 (0.799-5.058) | 0.138 | |
| Neobladder vs. Ileal conduit1 | 0.998 (0.441-2.259) | 0.997 | |
| Others 2 vs. Ileal conduit 1 | 11.259 (1.205-105.225) | 0.033 | |
| Preoperative diagnosis (Others vs. Bladder cancer 1) | 0.511 (0.217-1.202) | 0.124 | |
| Radical cystectomy vs. Simple cystectomy 1 | 0.916 (0.409-2.054) | 0.832 | |
| Smoking status | |||
| Former smoker vs. Never smoker 1 | 2.768 (1.082-7.075) | 0.033 | |
| Current smoker vs. Never smoker 1 | 1.545 (0.563-4.237) | 0.398 | |
| Diabetes Mellitus (Yes vs. No 1) | 2.516 (1.274-4.970) | 0.008 | |
| Neoadjuvant Chemotherapy (Yes vs. No 1) | 0.513 (0.244-1.078) | 0.078 | |
| Intravesical treatment (Yes vs. No 1) | 2.198 (1.013-4.767) | 0.046 | |
| Pelvic Radiation therapy (Yes vs. No 1) | 2.036 (0.754-5.497) | 0.160 | |
| ECOG (≥1 vs. 0 1) | 0.816 (0.407-1.638) | 0.568 | |
| ASA (≥4 vs. ≤31) | 3.005 (1.187-7.601) | 0.020 | |
| ACCI (≥7 vs. ≤61) | 2.126 (1.043-4.330) | 0.037 | |
| Multivariable | |||
| Gender (Male vs. Female1) | 1.685 (0.717-3.959) | 0.230 | |
| Diversion type | |||
| Indiana Pouch vs. Ileal conduit 1 | 1.435 (0.448-4.594) | 0.542 | |
| Neobladder vs. Ileal conduit 1 | 0.853 (0.340-2.138) | 0.734 | |
| Others 2 vs. Ileal conduit 1 | 2.695 (0.168-43.215) | 0.483 | |
| Smoking status | |||
| Former smoker vs. Never smoker 1 | 3.354 (1.094-10.285) | 0.034 | |
| Current smoker vs. Never smoker 1 | 2.354 (0.733-7.558) | 0.150 | |
| Diabetes Mellitus (Yes vs. No 1) | 2.327 (1.111-4.858) | 0.025 | |
| Intravesical treatment (Yes vs. No 1) | 1.893 (0.776-4.616) | 0.160 | |
| ASA (≥4 vs. ≤3 1) | 1.719 (0.552-5.355) | 0.345 | |
| ACCI (≥7 vs. ≤6 1) | 1.585 (0.687-3.657) | 0.280 | |
ASA = American Society of Anesthesiology score; ACCI = Age-adjusted Charlson Comorbidity Index scores; ECUD = extracorporeal urinary diversion; ECOG = Eastern Cooperative Oncology Group performance status; ICUD = intracorporeal urinary diversion; SD = standard deviation;
1
calculated as a reference
2
Including percutaneous ureterostomy, ureterosigmoidostomy, colon conduit, etc